Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the unchanged 403 error page.
    Difference
    1%
    Check dated 2026-10-24T15:16:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays a newer site revision number, changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:57:01.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:49:36.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Access to the study's main content is now blocked by a 403 Forbidden page, replacing the usual trial details. This prevents users from viewing core information about the trial on the public page.
    Difference
    18%
    Check dated 2026-09-19T18:20:21.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page adds a U.S. NIH Grant/Contract funding note and updates the page revision from v3.6.5 to v3.6.6.
    Difference
    0.0%
    Check dated 2026-08-29T20:12:00.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.6.5, has been added to the page, indicating an updated version of the study details (replacing v3.6.4); the Plain Language Summary section has been removed from the page.
    Difference
    0.0%
    Check dated 2026-08-08T18:46:53.000Z thumbnail image

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.